-- Sigma Pharma Extends Aspen of South Africa's Exclusivity Period to July 5
-- Victoria Batchelor
-- 2010-06-25T06:05:02Z
-- http://www.bloomberg.com/news/2010-06-25/sigma-pharma-extends-aspen-of-south-africa-s-exclusivity-period-to-july-5.html

          
          
             Sigma Pharmaceuticals Ltd. has
agreed to extend the exclusivity period for Aspen Pharmacare
Holdings Ltd. to 5 July to enable Aspen to complete its due
diligence review.  
 “The due diligence process being undertaken by Aspen may
or may not result in a formal proposal or a recommendation by
the board,” Sigma said.  
          
          


  


        